Latest Breaking News On - Melissa tosca - Page 1 : comparemela.com

Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences

Kiora Pharmaceuticals, Inc. , will participate in two upcoming investor conferences that will be available to investors live with the replay available on-demand. On Wednesday May 22, at 3:00 pm.

Brian stremCalifornia newsfile corpKiora pharmaceuticalsKiora pharmaceuticals incWednesday mayEastern timeExecutive vice presidentMelissa toscaWebull corporate connect biotech investmentLytham partners springLytham partners

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease

Kiora Pharmaceuticals Reports First Quarter Results; Update on Pipeline of Drugs Targeting Retinal Disease
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesBrianm stremUniversity of californiaKiora pharmaceuticalsKiora pharmaceuticals incAssociation of researchCalifornia newsfile corpOpen innovationMelissa toscaInvestigational new drugInitiate phasePrivate securities litigation reform actAnnual reportCurrent assetsRelease assetsCurrent liabilities

Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc. today announced its 2023 financial results and provided an update on its retinal disease development pipeline. The Company s major initiatives planned for 2024 are to.

Brianm stremCalifornia newsfile corpKiora pharmaceuticals incKiora pharmaceuticalsOpen innovationMelissa toscaUpcoming milestonesOrphan drug designationsPrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Reports 2023 Results; Continues to Advance Pipeline of Treatments for Rare Retinal Diseases
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Brianm stremDennis riedlKiora pharmaceuticals incCalifornia newsfile corpKiora pharmaceuticalsOpen innovationMelissa toscaUpcoming milestonesOrphan drug designationsPrivate securities litigation reform actAnnual report

Kiora Pharmaceuticals, Inc : Kiora Pharmaceuticals Provides 3rd Quarter 2022 Business and Financial Update; Dosing of KIO-301 in Phase 1 Trial for Retinitis Pigmentosa to Begin Before Year s End

Salt Lake City, Utah (Newsfile Corp. - November 9, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results

New south walesSalt lake cityUnited statesFrancina agostiEric danielsBrianm stremUtah newsfile corpKiora pharmaceuticalsKiora pharmaceuticals incChief executive officerRetinitis pigmentosaPersistent corneal epithelial defectsRheumatoid arthritisPersistent corneal epithelialMelissa toscaExecutive vice president